Uncoupling Therapeutic Efficacy from Immune-Related Adverse Events in Immune Checkpoint Blockade

Immunotherapy with monoclonal antibodies targeting immune checkpoint molecules, including programmed death-1 (PD-1), PD ligand-1 (PD-L1), and cytotoxic T-lymphocyte-associated antigen (CTLA)-4, has become prominent in the treatment of many types of cancer. However, a significant number of patients t...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:iScience
Huvudupphovsmän: Hu, Weilei, Wang, Guosheng, Wang, Yian, Riese, Matthew J., You, Ming
Materialtyp: Artigo
Språk:Inglês
Publicerad: Elsevier 2020
Ämnen:
Review
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7554032/
https://ncbi.nlm.nih.gov/pubmed/33083746
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.isci.2020.101580
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk